CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 58 enrolled
Drug / intervention
Surgeryprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01982968
NCT01982968N/ACompleted
CompareCT.gov

Weighing Risks and Benefits of Laparoscopic Anti-Reflux Surgery in Patients With Idiopathic Pulmonary Fibrosis

University of California, San Francisco·interventional·Posted Nov 13, 2013·Updated Oct 25, 2021

In Brief

A clinical study evaluating Surgery for Idiopathic Pulmonary Fibrosis and Gastroesophageal Reflux. Completed, enrolled 58 participants across 5 sites.

Detailed Summary

This study will test the hypothesis that treatment with laparoscopic anti-reflux surgery in subjects with idiopathic pulmonary fibrosis (IPF) and abnormal gastroesophageal reflux (GER) will slow the decline of forced vital capacity (FVC) over 48 weeks.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIdiopathic Pulmonary Fibrosis, Gastroesophageal Reflux
CountriesUnited States
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedNov 13, 2013
Enrollment StartDec 1, 2013
Primary CompletionNov 1, 2017
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 12.6 years ago

Interventions

Surgeryprocedure

Full fundoplication surgery for the treatment of abnormal GER